These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The Role of Mesenchymal Stem Cells in Modulating the Breast Cancer Microenvironment. Zhang L Cell Transplant; 2023; 32():9636897231220073. PubMed ID: 38135917 [TBL] [Abstract][Full Text] [Related]
6. Composition of Conditioned Media from Radioresistant and Chemoresistant Cancer Cells Reveals miRNA and Other Secretory Factors Implicated in the Development of Resistance. Molodtsova D; Guryev DV; Osipov AN Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003688 [TBL] [Abstract][Full Text] [Related]
7. The Role of Mesenchymal Stem Cells and Exosomes in Tumor Development and Targeted Antitumor Therapies. Yang E; Jing S; Wang Y; Wang H; Rodriguez R; Wang Z Stem Cells Int; 2023; 2023():7059289. PubMed ID: 36824409 [TBL] [Abstract][Full Text] [Related]
8. Breast Cancer Therapy: The Potential Role of Mesenchymal Stem Cells in Translational Biomedical Research. Gentile P Biomedicines; 2022 May; 10(5):. PubMed ID: 35625915 [TBL] [Abstract][Full Text] [Related]
10. Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice. Abusarah J; Khodayarian F; El-Hachem N; Salame N; Olivier M; Balood M; Roversi K; Talbot S; Bikorimana JP; Chen J; Jolicoeur M; Trudeau LE; Kamyabiazar S; Annabi B; Robert F; Pelletier J; El-Kadiry AE; Shammaa R; Rafei M Cell Rep Med; 2021 Dec; 2(12):100455. PubMed ID: 35028603 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy. Hassanzadeh A; Altajer AH; Rahman HS; Saleh MM; Bokov DO; Abdelbasset WK; Marofi F; Zamani M; Yaghoubi Y; Yazdanifar M; Pathak Y; Chartrand MS; Jarahian M Front Cell Dev Biol; 2021; 9():686453. PubMed ID: 34322483 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines. Liang W; Chen X; Zhang S; Fang J; Chen M; Xu Y; Chen X Cell Mol Biol Lett; 2021 Jan; 26(1):3. PubMed ID: 33472580 [TBL] [Abstract][Full Text] [Related]
13. Genetically engineered mesenchymal stem cells: targeted delivery of immunomodulatory agents for tumor eradication. Mosallaei M; Simonian M; Ehtesham N; Karimzadeh MR; Vatandoost N; Negahdari B; Salehi R Cancer Gene Ther; 2020 Dec; 27(12):854-868. PubMed ID: 32418986 [TBL] [Abstract][Full Text] [Related]
14. Progress in the application of organoids to breast cancer research. Yang L; Liu B; Chen H; Gao R; Huang K; Guo Q; Li F; Chen W; He J J Cell Mol Med; 2020 May; 24(10):5420-5427. PubMed ID: 32283573 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice. Stamatopoulos A; Stamatopoulos T; Gamie Z; Kenanidis E; Ribeiro RDC; Rankin KS; Gerrand C; Dalgarno K; Tsiridis E J Bone Oncol; 2019 Jun; 16():100231. PubMed ID: 30956944 [TBL] [Abstract][Full Text] [Related]
16. In vitro biomimetic engineering of a human hematopoietic niche with functional properties. Bourgine PE; Klein T; Paczulla AM; Shimizu T; Kunz L; Kokkaliaris KD; Coutu DL; Lengerke C; Skoda R; Schroeder T; Martin I Proc Natl Acad Sci U S A; 2018 Jun; 115(25):E5688-E5695. PubMed ID: 29866839 [TBL] [Abstract][Full Text] [Related]